Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BIX-01294 是高度选择性的G9a 和GLP 组蛋白甲基转移酶可逆抑制剂。它通过与底物赖氨酸残基 N 端的氨基酸竞争结合来抑制 G9a/GLP,可诱导坏死性凋亡和自噬,具有抗肿瘤活性。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 269 | 现货 | ||
2 mg | ¥ 378 | 现货 | ||
5 mg | ¥ 595 | 现货 | ||
10 mg | ¥ 957 | 现货 | ||
25 mg | ¥ 1,790 | 现货 | ||
50 mg | ¥ 3,180 | 现货 | ||
100 mg | ¥ 4,360 | 现货 | ||
200 mg | ¥ 6,430 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 995 | 现货 |
产品描述 | BIX-01294 is an G9a Histone Methyltransferase inhibitor(IC50 : 1.9 μM). |
靶点活性 | G9a:1.9 μM |
体外活性 | BIX-01294 induced caspase-dependent apoptosis in human bladder cancer cells.?BIX-01294 stimulates endoplasmic reticulum stress (ER stress) and up-regulated expression of PMAIP1 through DDIT3 up-regulation.?Furthermore, down-regulation of the deubiquitinase USP9X by BIX-01294 results in downstream reduction of MCL1 expression, leading to apoptosis eventually[1]. |
细胞实验 | On the first day, cells were seeded in 96 well plates.?Twenty-four hours later, BIX-01294 was added at the indicated concentrations in each well.?After treatment by BIX-01294 for another 24 h, we used 10% TCA to immobilize the cells and then evaluated the living cell numbers using the sulforhodamine B assay as previously described[1] |
分子量 | 490.64 |
分子式 | C28H38N6O2 |
CAS No. | 935693-62-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 98 mg/mL (163.33 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.0382 mL | 10.1908 mL | 20.3815 mL | 50.9539 mL |
5 mM | 0.4076 mL | 2.0382 mL | 4.0763 mL | 10.1908 mL | |
10 mM | 0.2038 mL | 1.0191 mL | 2.0382 mL | 5.0954 mL | |
20 mM | 0.1019 mL | 0.5095 mL | 1.0191 mL | 2.5477 mL | |
50 mM | 0.0408 mL | 0.2038 mL | 0.4076 mL | 1.0191 mL | |
100 mM | 0.0204 mL | 0.1019 mL | 0.2038 mL | 0.5095 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
BIX-01294 935693-62-2 Autophagy Chromatin/Epigenetic Histone Methyltransferase PRMT1 recurrent H3K9me3 Inhibitor Cdkn1a inhibit p53 Gadd45a MLKL BIX 01294 SUV39H1(H320R) H3K9me2 BIX01294 p21 inhibitor